0000886163-17-000029.txt : 20170228 0000886163-17-000029.hdr.sgml : 20170228 20170228182713 ACCESSION NUMBER: 0000886163-17-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170215 FILED AS OF DATE: 20170228 DATE AS OF CHANGE: 20170228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOEHR MATTHEW W CENTRAL INDEX KEY: 0001237556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 17650090 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES RD #200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-02-15 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001237556 FOEHR MATTHEW W 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121 0 1 0 0 President and COO Common Stock 2017-02-15 4 F 0 1642 104.28 D 81395 D Common Stock 2017-02-15 4 F 0 725 104.28 D 80670 D Common Stock 2017-02-24 4 A 0 5239 0.0 A 85909 D Common Stock 2017-02-24 4 F 0 2733 100.38 D 83176 D Common Stock 2017-02-24 4 A 0 7544 0.0 A 90720 D Employee Stock Option (right to buy) 100.38 2017-02-24 4 A 0 25376 0.0 A 2027-02-24 Common Stock 25376 25376 D Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/10/2015. Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2016. Represents the number of shares of common stock issued upon the vesting of performance stock units (PSUs). Each PSU represented a contingent right to receive one share of the Issuer?s common stock. The PSUs were originally granted on 02/10/2015 and were eligible to vest based on the Issuer?s achievement of certain performance objectives during the two-year performance period ending December 31, 2016. On February 24, 2017, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer?s achievement relative to the applicable performance objectives and approved the vesting of the PSUs with respect to these shares. Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of the PSUs. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter. By: Charles S. Berkman For: Matthew W. Foehr 2017-02-28